Reports Q1 revenue $9.8M, consensus $9.22M. “Our first quarter financial results were in line with expectations, yet several operating metrics were affected by continued utilization management by Medicare Advantage plans which impacted authorizations and orders, as well as changes to social media algorithms that disrupted lead flow and increased our cost per pipeline add during the first six weeks of the quarter. I’m pleased to report that both lead flow and pipeline adds rebounded in March and April,” said Paul R. Gudonis, Myomo’s (MYO) Chairman and Chief Executive Officer.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYO:
- Myomo Announces Board Transition with Director Departures
- Myomo’s Strong Financial Performance and Promising Growth Prospects Drive Buy Rating
- Myomo price target raised to $9.50 from $7.50 at H.C. Wainwright
- Myomo Inc. Reports Record Growth Amid Challenges
- Myomo price target raised to $11 from $9 at Craig-Hallum